Antibiotic Resistance: Retrospective, Concurrent, and Prospective Data

Home > 2023, Vol. 11 No. 02 > Antibiotic Resistance: Retrospective, Concurrent, and Prospective Data

Published: November 10, 2023

Download PDF

Download XML | Download HTML

Authors

Bhavesh Dharmani, Sarita Jangra, Bisman Kaur, and Thakur Gurjeet Singh

DOI Number
https://doi.org/10.15415/jprtm.2023.112006

Keywords
Antibiotic Resistance; Rationale Use; Pollution; Antibiotics Use

Abstract

Background: Over decades, antimicrobial medicines have been extensively used in industries such as agriculture and cattle husbandry, not only for the treatment of illnesses but also as preventative measures. Because of this extensive usage, bacteria have unintentionally developed antibiotic resistance (ABR), sometimes without the host’s knowledge. It has made treating infectious infections more unclear and difficult.

Purpose: This review examines the patterns of antibiotic use and the types of bacteria that have developed resistance. It also explores their therapeutic mechanisms of action and the mechanisms behind resistance development. Additionally, the review discusses retrospective and concurrent data on ABR and proposes a prospective approach for the surveillance and monitoring of ABR globally.

Method: The review analyses both historical and current data on the global use of antimicrobial agents and their impact on antibiotic resistance. It assesses various strategies for the rational use of antibiotics, considering past patterns and current trends in ABR. The study also evaluates ongoing efforts to monitor and prevent the spread of ABR.

Result: Here, findings highlight the widespread and growing issue of antibiotic resistance, driven by both human and agricultural use of antibiotics. The review underscores the significance of continuous surveillance, monitoring, and the rational use of antimicrobial agents to combat the global threat of ABR, ensuring more effective management of infectious diseases.

Conclusion: Urgent global action is needed against antibiotic resistance because of both human and agricultural use. Improved surveillance and rational use of antibiotics are a prerequisite for preserving the efficacy of treatments available today and for maintaining public health. Strategic planning ahead will be the best management of infectious diseases.

References

Alekshun, M. N., & Levy, S. B. (2007). Molecular mechanisms of antibacterial multidrug resistance. Cell, 128(6), 1037–1050. https://doi.org/10.1016/j.cell.2007.03.004
Ben, Y., Fu, C., Hu, M., Liu, L., Wong, M. H., & Zheng, C. (2019). Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review. Environmental research, 169, 483–493. https://doi.org/10.1016/j.envres.2018.11.040
Benzian, H., Beltrán-Aguilar, E., & Niederman, R. (2023). Global health threats are also oral health threats. Journal of the American Dental Association (1939), 154(5), 367–369. https://doi.org/10.1016/j.adaj.2023.01.007
Berrazeg, M., Jeannot, K., NtsogoEnguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015). Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. Antimicrobial agents and chemotherapy, 59(10), 6248–6255. https://doi.org/10.1128/AAC.00825-15
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 48(1), 1–12. https://doi.org/10.1086/595011
Cepas, V., & Soto, S. M. (2020). Relationship between Virulence and Resistance among Gram-Negative Bacteria. Antibiotics (Basel, Switzerland), 9(10), 719. https://doi.org/10.3390/antibiotics9100719
Dehbashi, S., Tahmasebi, H., Alikhani, M. Y., Keramat, F., & Arabestani, M. R. (2020). Distribution of Class B and Class A β-Lactamases in Clinical Strains of Pseudomonas aeruginosa: Comparison of Phenotypic Methods and High-Resolution Melting Analysis (HRMA) Assay. Infection and drug resistance, 13, 2037–2052. https://doi.org/10.2147/IDR.S255292
Friedrich A. W. (2019). Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go. Wiener medizinische Wochenschrift, 169(1), 25–30. https://doi.org/10.1007/s10354-018-0676-5
Gaynes R. (2017). The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Use. Emerging Infectious Diseases, 23(5), 849–853. https://doi.org/10.3201/eid2305.161556
Grundmann, H., Klugman, K. P., Walsh, T., Ramon-Pardo, P., Sigauque, B., Khan, W., Laxminarayan, R., Heddini, A., & Stelling, J. (2011). A framework for global surveillance of antibiotic resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy, 14(2), 79–87. https://doi.org/10.1016/j.drup.2011.02.007
Hansen, S., Lewis, K., & Vulić, M. (2008). Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrobial agents and chemotherapy, 52(8), 2718–2726. https://doi.org/10.1128/AAC.00144-08
Henrichfreise, B., Wiegand, I., Pfister, W., & Wiedemann, B. (2007). Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrobial agents and chemotherapy, 51(11), 4062–4070. https://doi.org/10.1128/AAC.00148-07
Hwang, W., & Yoon, S. S. (2019). Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa. Scientific reports, 9(1), 487. https://doi.org/10.1038/s41598-018-37422-9
Iramiot, J. S., Kajumbula, H., Bazira, J., Kansiime, C., & Asiimwe, B. B. (2020). Antimicrobial resistance at the human-animal interface in the Pastoralist Communities of Kasese District, South Western Uganda. Scientific reports, 10(1), 14737. https://doi.org/10.1038/s41598-020-70517-w
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021). Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors. International journal of molecular sciences, 22(6), 3128. https://doi.org/10.3390/ijms22063128
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. Journal of bacteriology, 186(24), 8172–8180. https://doi.org/10.1128/JB.186.24.8172-8180.2004
Lafleur, M. D., Qi, Q., & Lewis, K. (2010). Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrobial agents and chemotherapy, 54(1), 39–44. https://doi.org/10.1128/AAC.00860-09
Levin, B. R., & Rozen, D. E. (2006). Non-inherited antibiotic resistance. Nature reviews. Microbiology, 4(7), 556–562. https://doi.org/10.1038/nrmicro1445
Lewis K. (2013). Platforms for antibiotic discovery. Nature reviews. Drug discovery, 12(5), 371–387. https://doi.org/10.1038/nrd3975
Malik, B., & Bhattacharyya, S. (2019). Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Scientific reports, 9(1), 9788. https://doi.org/10.1038/s41598-019-46078-y
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021). Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens (Basel, Switzerland), 10(10), 1310. https://doi.org/10.3390/pathogens10101310
Munita, J. M., & Arias, C. A. (2016). Mechanisms of Antibiotic Resistance. Microbiology spectrum, 4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015
Ontong, J. C., Ozioma, N. F., Voravuthikunchai, S. P., &Chusri, S. (2021). Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PloS one, 16(1). https://doi.org/10.1371/journal.pone.0244673
Poole K. (2005). Efflux-mediated antimicrobial resistance. The Journal of antimicrobial chemotherapy, 56(1), 20–51. https://doi.org/10.1093/jac/dki171
Rehni, A. K., Singh, T. G., Jaggi, A. S., & Singh, N. (2008). Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. Pharmacological reports: PR, 60(6), 904–913.
Sharma, A., Mittal, A., Puri, V., Kumar, P. and Singh, I. (2020). Curcumin-loaded, alginate–gelatin composite fibers for wound healing applications. 3 Biotech, 10, 464. https://doi.org/10.1007/s13205-020-02453-5
Sun, D., Jeannot, K., Xiao, Y., & Knapp, C. W. (2019). Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance. Frontiers in microbiology, 10, 1933. https://doi.org/10.3389/fmicb.2019.01933
Thakur, A. K., Chellappan, D. K., Dua, K., Mehta, M., Satija, S., & Singh, I. (2020). Patented therapeutic drug delivery strategies for targeting pulmonary diseases. Expert opinion on therapeutic patents, 30(5), 375–387. https://doi.org/10.1080/13543776.2020.1741547
Thomas, C. M., & Nielsen, K. M. (2005). Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nature reviews. Microbiology, 3(9), 711–721. https://doi.org/10.1038/nrmicro1234
Waksman, S. A. (1973). History of the word ‘antibiotic’. Journal of the history of medicine and allied sciences, 28(3), 284-286. https://doi.org/10.1093/jhmas/xxviii.3.284

How to Cite

Bhavesh Dharmani, Sarita Jangra, Bisman Kaur, and Thakur Gurjeet Singh. Antibiotic Resistance: Retrospective, Concurrent, and Prospective Data. J. Pharm. Technol. Res. Manag.. 2023, 11, 133-141

Antibiotic Resistance: Retrospective, Concurrent, and Prospective Data

Current Issue

Periodicity	Biannually
Issue-1	May
Issue-2	November
ISSN Print	2321-2217
ISSN Online	2321-2225
RNI No.	CHAENG/2013/50088

OA Policy

Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy

Plan-S Compliance

To check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.

Recommend journal to your library

You can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal

Preprint Arxiv Submission

The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).

Contact: Phone: +91-172-2741000, +91-172-4691800

Email : editor.jptrm@chitkara.edu.in;

Abstract and Indexing

Information

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/